|
Feline Panleukopenia Virus
|
B04.280.580.650.600.325 |
|
|
Biopolymers
|
D25.720.099 |
|
|
Etomidate
|
D03.383.129.308.265 |
|
|
Calgranulin A
|
D040501 |
[A 10.8-kDa member of the S-100 family of calcium-binding proteins that can form homo- or heterocomplexes with CALGRANULIN B and a variety of other proteins. The calgranulin A/B heterodimer is known as LEUKOCYTE L1 ANTIGEN COMPLEX. Calgranulin A is found in many cell types including GRANULOCYTES; KERATINOCYTES; and myelomonocytes, and has been shown to act as a chemotactic substance for NEUTROPHILS. Because it is present in acute inflammation but absent in chronic inflammation, it is a useful biological marker for a number of pathological conditions.
] |
|
Plantaginaceae
|
B01.650.940.800.575.912.250.583.700 |
|
|
Calgranulin B
|
D040502 |
[A 13.2-kDa member of the S-100 family of calcium-binding proteins that can form homo- or heterocomplexes with CALGRANULIN A and a variety of other proteins. The calgranulin A/B heterodimer is known as LEUKOCYTE L1 ANTIGEN COMPLEX. Calgranulin B is expressed at high concentrations in GRANULOCYTES during early monocyte differentiation, and serum calgranulin B levels are elevated in many inflammatory disorders such as CYSTIC FIBROSIS.
] |
|
Endocannabinoids
|
D10.251.265 |
|
|
Olivopontocerebellar Atrophies
|
C10.177.575.550.375 |
|
|
Nitrosation
|
D015538 |
[Conversion into nitroso compounds. An example is the reaction of nitrites with amino compounds to form carcinogenic N-nitrosamines.
] |
|
Cocarcinogenesis
|
C04.697.098.875 |
|
|
Fadrozole
|
D03.383.129.308.270 |
|
|
Platelet Activation
|
D015539 |
[A series of progressive, overlapping events, triggered by exposure of the PLATELETS to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
] |
|
Coffea
|
D040503 |
[A plant genus of the family RUBIACEAE. It is best known for the COFFEE beverage prepared from the beans (SEEDS).
] |
|
Down-Regulation
|
D015536 |
[A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins.
, A negative regulatory process that decreases ligand-receptor interactions. Reduction in receptor binding after ligand exposure can result from the internalization of ligand-receptor complex, an increase in receptor degradation, and/or a decrease in gene expression resulting in a decrease in receptor biosynthesis.
] |
|
Radiation Protection
|
N06.850.810.425 |
|
|
Rodentia
|
B01.050.150.900.649.313.992 |
|
|
Diaphragmatic Eventration
|
C06.198.257 |
|
|
Optic Atrophy, Hereditary, Leber
|
C11.270.564.400 |
|
|
Polyisoprenyl Phosphate Oligosaccharides
|
D09.894.680.710 |
|
|
Polyisoprenyl Phosphate Sugars
|
D09.894.680 |
|
